✉news HealthHealth first seen 5 h ago, last 2 h ago, peak #10
CD&R and McKesson to Buy At-Home Infusion Provider for $5.8 Billion
Original: CD&R, McKesson to Acquire At-Home Infusion Therapy Provider for $5.8 Billion
Private equity firm Clayton, Dubilier & Rice and healthcare distributor McKesson have agreed to acquire an at-home infusion therapy provider in a deal valued at $5.8 billion. The acquisition underscores continued investor interest in home-based healthcare services, a segment growing as more patients receive complex treatments like infusion therapy outside hospitals.
Why now: Major healthcare deal activity in the fast-growing home infusion and home-based care market is drawing attention from investors and industry watchers.
Clayton, Dubilier & RiceMcKesson
Rank over time, top of the chart is #1. 3 snapshots from 5 h ago to 2 h ago.
Evidence
API: https://socialmediatrends-api.osmike.com/v1/trends/1252314